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ABSTRACT: Biological membranes present a highly ﬂuid
environment, and integration of proteins within such mem-
branes is itself highly dynamic: proteins diﬀuse laterally
withintheplaneofthemembraneandrotationallyaboutthe
normal vector of this plane. We demonstrate that whole-
body motions of proteins within a lipid bilayer can be
determined from NMR
15N relaxation rates collected for
diﬀerent-sized bicelles. The importance of membrane inte-
gration and interaction is particularly acute for proteins and
peptides that function on the membrane itself, as is the case
for pore-forming and fusion-inducing proteins. For the
inﬂuenza hemagglutinin fusion peptide, which lies on the
surface of membranes and catalyzes the fusion of mem-
branes and vesicles, we found large-amplitude, rigid-body
wobbling motions on the nanosecond time scale relative to
the lipid bilayer. This behavior complements prior analyses
where data were commonly interpreted in terms of a static
obliqueangleofinsertionforthefusionpeptidewithrespect
to the membrane. Quantitative disentanglement of the
relative motions of two interacting objects by systematic
variation of the size of one is applicable to a wide range of
systems beyond protein membrane interactions.
I
nﬂuenza hemagglutinin (HA) is a viral fusion glycoprotein
composed of a homotrimer of two subunits, HA1 and HA2,
and itisresponsibleforfusingthemembraneof theviral envelope
to that of the host-cell endosome.
1 Within the endosome, a
decrease in pH induces a conformational change that exposes
and anchors the ∼23 N-terminal residues of the HA2 subunit,
2
known as the hemagglutinin fusion peptide or HAfp23, into the
endosomal membrane. Even conservative mutations in this
N-terminal sequence of hemagglutinin can abrogate its ability to
fuse membranes,
3 but the N-terminal peptide alone is suﬃcient
to promote fusion of lipid vesicles.
4
The HAfp23 domain adopts a tight antiparallel helical hairpin
structure with its hydrophobic face buried in the membrane and
its more polar face exposed to solvent.
5 The membrane integra-
tion of HAfp20, a truncated and less structured peptide lacking
three completely conserved C-terminal residues, adopts a more
open and dynamically less ordered structure but remains
fusogenic.
4,6,7 There is considerable evidence that anchoring of
the fusion peptide in a lipid bilayer causes the formation of high-
curvature states of the membrane surface, which can enable
membranefusion.
8,9Accordingly,therehas beenkeen interestin
its speciﬁc position and orientation within the membrane, with
results suggesting thatanobliqueangle of insertion isrequired for
fusogenicity of fusion peptides.
10,11
Attenuated totalreﬂectanceFouriertransformIRspectroscopy
(ATR-FTIR) hasbeenparticularlyfruitfulinthispursuit.
6,9,10,12,13
ThistechniquemeasuresthedichroicratiosoftheamideI0 bands
to derive the average peptide group transition dipole orienta-
tional order parameter, and thereby the helical axis orientation,
relative to the membrane normal. Though there is some disagree-
mentontheexactvalueoftheorderparameterforHAfp,resultshave
beeninterpretedintermsofastaticobliqueangleofinsertionintothe
membrane under “the simplifying assumption that all peptides [are]
alignedatthesameangleinagivensample”.
6Otherapproacheshave
relied on neutron diﬀraction
14 and electron paramagnetic resonance
(EPR) to measure immersion depths and angles.
13 These latter
studiesusedparamagneticprobesattachedtosinglecysteinevariants
of the peptides.
15 Although this approach can precisely ascertain the
depthoftheseprobesinthemembrane,andfromthattheorientation
ofanR-helix,thebiologicalimplicationsofthoseresultsareimpacted
by the ﬁnding that such probes can signiﬁcantly alter the fusion
peptide’s location in a lipid bilayer.
16 Moreover, mutations even
more conservative than replacement of a cysteine often abolish the
fusogenic activity of these peptides.
3A second problem is that for all
of these measurements, it remains diﬃcult to separate the eﬀect of
average orientation from the width of the dynamic distribution
adopted by the peptide.
NMR spectroscopy is potentially well-suited for answering
questionsregarding membraneproteintopology
17 and dynamics
18
in membrane-mimetic and micellar environments. Here we use
a novel approach to evaluate quantitatively the orientational
distribution of HAfp23 relative to the planar bilayer component
of isotropic bicelles and the rate at which the fusion peptide
reorients relative to this bilayer.
Isotropic bicelles are mixed micelles composed of the deter-
gent dihexanoyl phosphatidylcholine (DHPC) or its hydrolysis-
resistant, ether-linked analogue dihexyl PC (DOHPC) and
dimyristoyl PC (DMPC). Below a [DMPC]/[DHPC] molar
ratio (q)o f∼2.5, these bicelles adopt a disk-shaped morphology
and tumble freely in solution. The detergent in such bicelles is
partitioned on the rim, whereas the plane of the bicelle provides
anexcellentmimicofapure DMPC bilayer.
19,20 Thediameter of
these bicelles scales steeply with q.
19,21 Model calculations
indicate that the diameter of the planar region of the bicelle
increases from ∼40 to ∼100 Å as q increases from 0.2 to 0.7,
corresponding to objects that are tens to hundreds of kDa in mass.
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Measuring the
15N relaxation rates of HAfp23 in micelles and
isotropic bicelles of increasing size allows the eﬀect of overall
tumbling of the lipid/peptide complex to be separated from the
motion of the HAfp23 within this complex. Prerequisites for this
analysis are that the HAfp23 retains the same structure and internal
dynamics and that its angular excursions relative to the water lipid
interface are independent of the size and composition of the
complex. Strong support for the structural and dynamic invariance
of HAfp23 embedded in micelles and bicelles with diﬀerent sizes is
found in the virtually indistinguishable resonance positions in
1H 
15N HSQC spectra (Figure 1).
The
15N relaxation rates of HAfp23 solubilized in DOHPC/
DMPC bicelles indicate a strong dependence on q (i.e., on the
size of the bicelle) (Figure 2). In addition to the rates previously
reported for HAfp23 in DPC micelles,
5 the data include mea-
surements taken for four diﬀerent sizes of bicelles [small (q =
0.29), medium (0.52 and 0.55), and large (0.69)] and two
magnetic ﬁelds (600 and 900 MHz
1H frequency). The relaxa-
tionratesforresiduesF3 G12andW14 Y22,whichconstitute
the two antiparallel R-helices, are highly homogeneous, as ex-
pected for
15N 
1H amide bonds that are tightly clustered in
orientation along the directions of the nearly antiparallel helical
axes.G23,whichcapsthesecondhelix,exhibitsincreasedinternal
dynamics, as evidenced by depressed
15N-{
1H} NOE and R2
[derived from R1F; see the Supporting Information (SI)] values.
Remarkably, G13 shows a higher R2, in particular for the large
bicelles, and this increase is nearly invariant with respect to the
magnetic ﬁeld strength (beyond what is expected on the basis of
the increased R2 contribution from
15N chemical shift an-
isotropy). This increased R2 therefore is not caused by con-
formational exchange but instead must be due to diﬀerent
dynamic behavior for this
15N 
1H pair, whose orientation is
roughly orthogonal to the other
15N 
1H dipoles.
When ﬁtted separately, the relaxation data acquired for each
of the HAfp23/phospholipid complexes can be ﬁt reasonably
well with the standard Lipari Szabo model-free formalism
22
(TableS2andFigureS2intheSI).Datarecordedforthepeptide
in DPC micelles and in the smallest bicelles (q = 0.29) show
relaxation behavior very similar to that typically seen for a
well-structured globular protein, yielding high order parameters
(S
2 > ∼0.9) with short internal correlation times (τi < ∼1 ns).
However, ﬁtting the relaxation rates measured at higher q values
(medium and large bicelles) required the inclusion of slower
internal motions (in the 2 10 ns range) with lower generalized
order parameters (S
2 = 0.6 0.8). Thus, the parameters describ-
ing the internal dynamics obtained from the separate ﬁts were
found to change considerably with bicelle size, in contradiction
with the virtually identical resonance positions.
Alternatively, the relaxation data can be analyzed under the
assumptionthattheinternaldynamicsofHAfp23isindependent
of the overall motion of the complex if the overall rotational
diﬀusion rate is treated as an adjustable parameter that depends
onthebicellesize.ThevariationintheﬁttedS
2andτivalueswith
bicelle size (see above) already indicates that no adequate ﬁti s
obtainable with the standard Lipari Szabo model-free approach
in such a simultaneous ﬁt (Figure S3). Instead, the extended
Lipari Szabomodel
23mustbeusedtoﬁtthedata,allowingfora
fast(picosecond)andslow(nanosecond)internalmotionprocess.
Under one scenario (model A), the
15N relaxation data recorded
at diﬀerent q values and magnetic ﬁeld strengths were ﬁt with a
single set of residue-speciﬁc order parameters and internal
correlation times by minimizing the following χ
2 residual:
χ2
n ¼ ∑
q
ðRobs
1,n  R
pred
1,n Þ
2=σ2
1,n
h
þð Robs
2,n  R
pred
2,n Þ
2=σ2
2,n þð NOEobs
n   NOEpred
n Þ
2=σ2
NOE,n
 
ð1Þ
where the summation over q includes data measured for the
micelleanddiﬀerentbicellesizes,theindexnreferstotheresidue
number, and the predicted relaxation rates R1
pred and R2
pred and
Figure 1. Superimposed TROSY HSQC spectra (600 MHz) of
HAfp23 in DPC micelles and small (q = 0.29), medium (q = 0.55),
and large (q = 0.69) bicelles, recorded at pH 7.3 ( 0.1 and 32  C using
0.3 ( 0.1 mM HAfp23 and 5% (w/v) DPC or 7 10% (w/v) bicelles.
Figure 2. (A, B)
15N relaxation rates R1 and R2 and (C)
15N-{
1H}
NOEs of HAfp23 in DPC micelles (purple) and DOHPC/DMPC
bicellesofdiﬀerentsizes:small(q=0.29, black);medium(q=0.52,red;
q =0.55, blue), and large(q= 0.69, green). Theq =0.55 sample was ata
lower pH (6.5) than the other samples (7.1 7.4). Data were measured
at 600 MHz (solid symbols) and 900 MHz (open symbols).14186 dx.doi.org/10.1021/ja2045309 |J. Am. Chem. Soc. 2011, 133, 14184–14187
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NOE
pred were calculated with the extended Lipari Szabo model.
Variables in this ﬁt include the fast and slow internal correlation
times τf,n and τs,n, their corresponding generalized order param-
eters Sf,n
2 and Ss,n
2 , and the global rotational correlation times τR,q
for each bicelle size. Overall rotation was treated as isotropic
because the bicelle forms an oblate spheroid with a rotational
diﬀusion anisotropy that does not exceed 1.25,
24 so the entire
span in eﬀective tumbling rates for the N H vectors cannot
exceed(8%.Theactualvariationintumblingratesisexpectedto
be much smaller than 8% because the NH vectors span a narrow
range of orientations, none parallel to the bilayer normal.
5
Inthis ﬁt usingmodelA,residue-speciﬁcv a l u e sf o rτf,n, τs,n, Sf,n
2 ,
andSs,n
2 wereforcedtoadoptthesamevalueforlipidcomplexesof
all sizes (for details, see the SI). The relaxation rates for the vast
majority of residues could be ﬁt nearly as well with this restricted
ﬁtting mode (Table S3), despite the inclusion of nearly 5 times
fewer adjustable parameters comparedwiththe original ﬁts where
the relaxation data obtained for each bicelle size were treated
independently. Remarkably, except for residue G13, which sepa-
rateshelices1and2,andtheC-terminalresidueG23ofhelix2,the
best-ﬁt τs and Ss
2 values obtained in this manner were found to
cluster in narrow ranges: Æτsæ =5 . 1( 1.4 nsand Ss
2 =0 . 7 4( 0.04.
The narrow clustering of the slow internal motion parameters
fortheHAfp23amideprotonsstronglysuggeststhattheseparam-
eterscorrespondtoasingledynamicprocess,namely,movement
ofthepeptideasarigidbodyrelativetothemoreslowlytumbling
phospholipidcomplex.Indeed,undertheassumptionofidentical
motionalparametersτsandSs
2fordiﬀerentresidues(model B),a
ﬁt of all the relaxation data for residues F3 G12 and W14 Y22
(Figure3)yieldedaχ
2nearlyaslowasthatobtainedformodelA,
despite the 2-fold reduction in adjustable parameters (Figure
S5). The best-ﬁt common τs and Ss
2 parameters are 5.1 ( 0.6 ns
and 0.71 ( 0.03, respectively. F-test statistics indicated that
separate internal motion ﬁt parameters are warranted for G13
and G23 (Figure S5). The low
15N-{
1H} NOE and R2 values
observedforG23areindicativeofrelativelylargeamplitude,high
frequency motions for this C-terminal residue of helix 2. The
relaxation rates for G13, whose N H vector is the only one
orientednearlyorthogonaltothetwoHAfp23helices(Figure4),
were also ﬁt considerably better with model A, which yielded a
shorterτsof2.4(0.3nsandahigherSs
2of0.80(0.01relativeto
the helical residues (Table S4).
Motionsofproteinsandpeptidesinmembranesgenerallyfallinto
two categories:
25 (1) axial diﬀusion around the membrane director
(or normal) axis and (2) oﬀ-axis “wobble”diﬀusion about vectors in
the planeof the membrane. The axialrotationaldiﬀusion correlation
times of a transmembrane helix in DPPC
26 and of gramicidin A in
DMPC bilayers
27 are ∼200 ns. The rotational correlation time of
HAfp23, which is ∼30% smaller than the gramicidin A dimer, may
then be estimated as ∼140 ns; this is considerably beyond even the
longesttimescale(τR=44ns) sampledinthelargestbicellesusedin
our study. Such motion therefore cannot signiﬁcantly contribute to
the rates measured in our
15N relaxation measurements. Moreover,
the Lipari Szabo generalized order parameter for rotational diﬀu-
sion about the bilayer normal is given by
22
S2 ¼ð 3c o s 2 θ  1Þ=2
   2 ð2Þ
where θ is the angle between the
1H 
15N dipole and the axis of
motion. The helices and backbone
1H 
15N bond vectors of HAfp23
are nearly parallel to the water lipid interface,
5corresponding to θ≈
90  or an order parameter of 0.25. Oblique orientations of its two
helical axes (within (50  of the membrane plane) would correspond
toorderparametersevenlowerthan0.25.Suchaxialdiﬀusiontherefore
isclearlyincompatiblewiththeorderparameterof0.71,rulingoutaxial
diﬀusion as the source of the observed slow internal motion.
The rigid body motion therefore must be dominated by rota-
tionsaboutthexandyaxes,chosentobeparallelandorthogonal
to the average helix axis orientation, respectively (Figure 4). The
Figure 3. Plots of the best-ﬁt predicted (pred) vs observed (obs) (a, b)
15N relaxation rates and (c)
15N-{
1H} NOEs for HAfp23 at 600 MHz (solid
circles) and 900 MHz (open circles). The results were obtained using the extended Lipari Szabo model
23 with identical values for the slow internal
correlationtime(τs=5.1ns)andorderparameter(Ss
2=0.71)inallcasesforresiduesPhe
3 Gly
12andTrp
14 Tyr
22alongwithuniform,residue-speciﬁc
ﬁtting parameters τf and Sf
2 for fast internal motion (model B; see Table S4). With the same overall rotational correlation times, the best-ﬁt internal
dynamic parameters were τs = 2.4 ns, Ss
2 = 0.80 for Gly
13 and τs = 3.6 ns, Ss
2 = 0.67 for Gly
23. The ﬁtted overall rotational correlation times were 10.9 ns
(DPC), 15.1 ns (q = 0.29), 26.6 ns (q = 0.52), 29.0 ns (q = 0.55), and 44.2 ns (q = 0.69). Colors correspond to values measured in DPC (purple) and
small (q = 0.29, black), medium (q = 0.52, red; q = 0.55, blue), and large (q = 0.69, green) bicelles.
Figure 4. C
R backbone representation (including backbone amide
15N 
1H pairs) for HAfp23 and its approximate location relative to
the plane of the water lipid interface, as previously derived from
intermolecular NOE measurements.
5 The axis system shown has its x
axis parallel to the average N H vector orientation of residues 3 12
and14 22anditszaxisorthogonaltotheplane.TheGly
13N Hvector
isnearlyparalleltotheyaxis.Theindicatedamplitudesofmotionarethe
valuesofGaussianaxialﬂuctuations
28abouttheyandxaxescorrespond-
ing to Ss
2 = 0.71 and 0.80, respectively.14187 dx.doi.org/10.1021/ja2045309 |J. Am. Chem. Soc. 2011, 133, 14184–14187
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helicalamideN Hvectorsare,onaverage,orientedparalleltothex
axis with a root-mean-square (rms) angle of 18 ,w h e r e a st h eG 1 3
N H is oriented nearly orthogonal to the x axis with an angle of
91 . When the slow time scale order parameters are modeled in
terms of a one-dimensional Gaussian axial ﬂuctuation model,
28 Ss
2=
0.71 corresponds to a Gaussian distribution with an rms ﬂuctuation
of σy =2 0   around the y axis relative to its time-averaged
orientation. Remarkably, use of a slightly smaller amplitude of
rocking motions around the x axis can account for the larger R2 for
G13,asreﬂectedinitsSs
2valueof0.80andcompatiblewithσx=16 .
Modeling the slow order parameters with a cone-diﬀusion model
yields half angles of 27  for the y axis and 22  for the x axis.
22
The observed HAfp23 wobbling represents motion within the
frame of the bicelle. Undulatory and collective motions of lipids
couldcontributetotheobservedwobbling,butsuchmotionsarefar
slowerthanobservedhere,andtheiramplitudeismuchsmaller.
29,30
Interestingly, a 5 ns time scale has been attributed to local lipid
wobblingmotionsinLRphaseDMPCbilayers,
29suggestingthatthe
lipid dynamics may drive the rocking motion of the fusion peptide.
Membrane integration lies at the heart of the hemagglutinin
fusionpeptide’sfunction.Ourresultsshowthattheorientationof
HAfp23 relative to the water phospholipid interface is highly
dynamic and must be considered when interpreting other types
of data that report on the angle of insertion relative to the lipid
bilayer. Our analysis probes the relative motions of two objects,
HAfp23 and the lipid bilayer, by changing the size of one of the
objects (the bicelle or micelle) without impacting the nature of
theinteraction.ThisapproachisanalogoustoexperimentsbyAl-
Hashimiand co-workers
31 that resolvemotionalmodesin multi-
helicalRNA structures by greatly extending the sizeof oneof the
helical stems. Indeed, varying the size of one of the interacting
objects in NMR relaxation studies permits enhanced probing of
dynamic aspects for a wide range of systems beyond protein 
membrane interactions, including motions in multidomain pro-
teins as well as protein protein and protein nucleic acid com-
plexes. Whole-body motions of smaller amplitude recently have
been observed for a small protein relative to its crystalline lattice,
manifesting themselves by their R1 contributions.
32 This corre-
spondstotheupperlimitwhenprobingsize-dispersedrelaxation.
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